within Pharmacolibrary.Drugs.ATC.A;

model A03AX12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 4.5e-06,
    adminDuration  = 600,
    adminMass      = 80 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A03AX12</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Phloroglucinol is a non-atropinic antispasmodic drug, primarily used to relieve smooth muscle spasms of the gastrointestinal and genitourinary tracts. It is currently used in several countries for the symptomatic treatment of painful spasms, but is not FDA approved in the United States.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adult individuals based on sparse literature and secondary sources. No original primary study with detailed pharmacokinetic parameters found.</p><h4>References</h4><ol><li><p>Corvino, A, et al., &amp; Pierantoni, GM (2023). Phloroglucinol-Derived Medications are Effective in Reducing Pain and Spasms of Urinary and Biliary Tracts: Results of Phase 3 Multicentre, Open-Label, Randomized, Comparative Studies of Clinical Effectiveness and Safety. <i>Advances in therapy</i> 40(2) 619–640. DOI:<a href=&quot;https://doi.org/10.1007/s12325-022-02347-3&quot;>10.1007/s12325-022-02347-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36443585/&quot;>https://pubmed.ncbi.nlm.nih.gov/36443585</a></p></li><li><p>Soleymani, S, et al., &amp; Abdollahi, M (2017). Clinical risks of St John&#x27;s Wort (Hypericum perforatum) co-administration. <i>Expert opinion on drug metabolism &amp; toxicology</i> 13(10) 1047–1062. DOI:<a href=&quot;https://doi.org/10.1080/17425255.2017.1378342&quot;>10.1080/17425255.2017.1378342</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28885074/&quot;>https://pubmed.ncbi.nlm.nih.gov/28885074</a></p></li><li><p>Wurglics, M, &amp; Schubert-Zsilavecz, M (2006). Hypericum perforatum: a &#x27;modern&#x27; herbal antidepressant: pharmacokinetics of active ingredients. <i>Clinical pharmacokinetics</i> 45(5) 449–468. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200645050-00002&quot;>10.2165/00003088-200645050-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16640452/&quot;>https://pubmed.ncbi.nlm.nih.gov/16640452</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A03AX12;
